Study Set Content:
undergoing initial clinical (i.e., in humans) evaluation for a particular condition or
indication
Investigational
undergoing bench or laboratory testing using animals or other models
Experimental
superseded by other technologies or demonstrated to be
ineffective or harmful
Obsolete/outmoded/abandoned
systematic evaluation of properties, effects or other impacts of health technology
Health Technology Assessment
structured analysis of a health technology, a set of
related technologies, or a technology-related issue that is performed for the purpose of providing input to
a policy decision
US Congress, Office of Technology Assessment 1994
a field of scientific research to inform policy and clinical decision making around the introduction and
diffusion of health technologies
Health Technology Assessment International 2013:
a multidisciplinary field that addresses the health impacts of technology, considering its specific
healthcare context as well as available alternatives
Health Technology Assessment International 2013:
a multidisciplinary process that summarizes
information about the medical, social, economic and ethical issues related to the use of a health
technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of
safe, effective, health policies that are patient focused and seek to achieve best value. Despite its policy
goals, HTA must always be firmly rooted in research and the scientific method
European network for Health Technology Assessment 2013
Health
Technology Assessment asks important questions about these technologies [drugs, devices, procedures,
settings of care, screening] such as: When is counselling better than drug treatment for depression? What
is the best operation for aortic aneurysms? Should we screen for human papilloma virus when doing
cervical smears? Should aspirin be used for the primary prevention of cardiovascular disease?
UK NHS National Institute for Health Research Health Technology Assessment Programme 2013:
UK NHS National Institute for Health Research Health Technology Assessment Programme 2013:
It answers
these questions by investigating four main factors: whether the technology
works, for whom, at what
cost, how it compares with the alternatives.
also known as “Universal Health Care Act,”
Republic Act 11223
has mandated Health Technology
Assessment as “a fair and transparent priority setting mechanism for the development of policies and
programs, regulation, and the determination of a range of entitlements” in recognition of the role of
evidence-informed policy and decision-making in pursuit of UHC. The Act mandates that“Every Filipino
shall be granted immediate eligibility and access to preventive, promotive, curative, rehabilitative, and
palliative care for medical, dental, mental and emergency health services, delivered either as
population-based or individual-based health services: Provided, that the goods and services to be included
shall be determined through a fair and transparent health technology assessment process.” Among others,
this mechanism leads to increased quality of care and saves the government from unnecessary
expenditures since only cost-effective technologies will be funded.
Republic Act 11223
Purposes of HTA
To inform or
Advise
Purposes of HTA
() about whether to permit the commercial use (e.g., marketing) of a drug, device
or other regulated technology
Payers (health care authorities, health plans, drug formularies, employers, etc.) about technology
() (whether or not to pay), ()(assigning proper codes to enable reimbursement), and
() (how much to pay)
Regulatory agencies, coverage, coding, reimbursement
Clinicians and patients about the () use of health care interventions for a particular patient’s
clinical needs and circumstances
Health professional associations about the role of a technology in () or. ()
Hospitals, health care networks, group purchasing organizations, and other health care organizations
about decisions regarding technology () and management
Appropriate, clinical protocols or practice guidelines, acquisition
() organizations for health technology and health care delivery regarding the
manufacture, performance, appropriate use, and other aspects of health care technologies
Government health department officials about undertaking () (e.g.,
immunization, screening, and environmental protection programs)
() and other political leaders about policies concerning technological innovation, research
and development, regulation, payment and delivery of health care
Standards-setting, public health programs, lawmakers
() companies about product development and marketing decisions
Investors and companies concerning venture capital funding, acquisitions and divestitures, and other
transactions concerning health care product and ()
Research agencies about evidence () and unmet health needs
Health care technology, service companies, gaps
created under Section 34.8 of the Universal Health Care
Act,
The Health Technology Assessment Council
The Health Technology Assessment Council (HTAC) created under Section 34.8 of the Universal Health Care
Act, has the following explicit functions under the law:
Facilitate provision of financing and coverage recommendations on health technologies to be financed by
() and ();
Oversee and coordinate the () process within DOH and PhilHealth, and
() and () existing health technologies financed by DOH and PhilHealth health benefit packages.
DOH and Philhealth, HTA, review and assess
is responsible for the development and submission of final recommendations to policy-
and decision-makers, based on the evidence appraisal of the different subcommittees.
The Core Committee
